Blood filter device tested for autoimmune disease control
NCT ID NCT04078698
Summary
This study documented how well the GLOBAFFIN® device works in real-world medical settings for people with autoimmune diseases. The device filters harmful antibodies from patients' blood to help control their conditions. Researchers tracked 34 adult patients who were already scheduled to receive this treatment as part of their regular care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Diakonissenkrankenhaus Flensburg
Flensburg, 24939, Germany
-
Städtisches Klinikum Braunschweig
Braunschweig, Lower Saxony, 38126, Germany
-
University of Ulm - Department of Neurology
Ulm, 89081, Germany
Conditions
Explore the condition pages connected to this study.